OTC · Financial Statements
Biora Therapeutics, Inc. (BIOR) Financial Statements
$0.22
OTC: BIOR
Market Cap $994994
Overview Financials Dividend Biora Therapeutics, Inc. most recently reported annual revenue of $0, net profit of $-124.0M. See the full income statement, balance sheet, and cash flow statement below, plus valuation and return ratios.
Annual Financials (USD)
Metric 2019 2020 2021 2022 2023 Revenue $144.0M $74.0M $1.0M $0 $0 Operating Profit $-140.0M $-108.0M $-118.0M $-62.0M $-67.0M Net Profit $-148.0M $-193.0M $-179.0M $-38.0M $-124.0M EPS $-80.17 $-86.30 $-46.42 $-6.40 $-78.70 Op Margin -97.3% -144.8% -9449.6% -20256.1% -1678575.0%
Balance Sheet (USD)
Metric 2019 2020 2021 2022 2023 Total Assets $102.0M $154.0M $109.0M $54.0M $31.0M Total Liabilities $186.0M $261.0M $194.0M $156.0M $133.0M Cash $33.0M $92.0M $88.0M $30.0M $15.0M Borrowings $73.0M $161.0M $126.0M $129.0M $47.0M
Cash Flow (USD)
Metric 2019 2020 2021 2022 2023 Operating Cash Flow $-106.0M $-166.0M $-167.0M $-64.0M $-48.0M Investing Cash Flow $13.0M $-10.0M $-2.0M $-2.0M $2.0M Financing Cash Flow $0 $-7.0M $120.0M $-2.0M $3.0M Net Cash Flow $-16.0M $59.0M $-4.0M $-58.0M $-15.0M Free Cash Flow $-110.0M $-171.0M $-168.0M $-65.0M $-49.0M
Valuation & Return Ratios
Metric Value PEG Ratio 0.00 EV / EBITDA -0.29 FCF Yield -4884.65% Quick Ratio 0.30 Interest Coverage -6.84 Return 1Y — Return 3Y — Return 5Y —
Screens featuring this stock